Sora Ely1,2, Dana A Dominguez1,2, Jeffrey B Velotta3. 1. Department of Surgery, University of California San Francisco-East Bay, Oakland. 2. Division of Thoracic Surgery, Kaiser Permanente Oakland Medical Center, CA. 3. Department of Surgery, Kaiser Permanente Oakland Medical Center, CA.
Abstract
INTRODUCTION: Some patients with cardiac stents will need thoracic surgery during the dual antiplatelet therapy (DAPT) period. When surgery cannot be safely delayed to allow 1 year of uninterrupted DAPT, appropriate perioperative management of anticoagulation is critical. CASE PRESENTATION: A patient treated with new drug-eluting stents and DAPT was concomitantly diagnosed with lung cancer and required a lobectomy. We describe the novel addition of ticagrelor (a short-acting oral antiplatelet agent) to eptifibatide (a short-acting intravenous antiplatelet agent) to bridge DAPT for surgery. DISCUSSION: This ticagrelor-eptifibatide perioperative bridge resulted in decreased preoperative hospitalization compared with eptifibatide alone. There were no associated perioperative cardiac or bleeding complications.
INTRODUCTION: Some patients with cardiac stents will need thoracic surgery during the dual antiplatelet therapy (DAPT) period. When surgery cannot be safely delayed to allow 1 year of uninterrupted DAPT, appropriate perioperative management of anticoagulation is critical. CASE PRESENTATION: A patient treated with new drug-eluting stents and DAPT was concomitantly diagnosed with lung cancer and required a lobectomy. We describe the novel addition of ticagrelor (a short-acting oral antiplatelet agent) to eptifibatide (a short-acting intravenous antiplatelet agent) to bridge DAPT for surgery. DISCUSSION: This ticagrelor-eptifibatide perioperative bridge resulted in decreased preoperative hospitalization compared with eptifibatide alone. There were no associated perioperative cardiac or bleeding complications.
Authors: Mikkel Schoos; Jaya Chandrasekhar; Usman Baber; Aarti Bhasin; Samantha Sartori; Melissa Aquino; Birgit Vogel; Serdar Farhan; Sabato Sorrentino; Annapoorna Kini; Mitchell Kruckoff; David Moliterno; Timothy D Henry; Giora Weisz; C Michael Gibson; Ioannis Iakovou; Antonio Colombo; P Gabriel Steg; Bernhard Witzenbichler; Alaide Chieffo; David Cohen; Thomas Stuckey; Cono Ariti; George Dangas; Stuart Pocock; Roxana Mehran Journal: Am J Cardiol Date: 2017-06-28 Impact factor: 2.778
Authors: Boris Bigalke; Peter Seizer; Tobias Geisler; Stephan Lindemann; Meinrad Gawaz; Andreas E May Journal: Clin Res Cardiol Date: 2009-03-13 Impact factor: 5.460
Authors: Victor A Ferraris; Sibu P Saha; Julie H Oestreich; Howard K Song; Todd Rosengart; T Brett Reece; C David Mazer; Charles R Bridges; George J Despotis; Kanae Jointer; Ellen R Clough Journal: Ann Thorac Surg Date: 2012-11 Impact factor: 4.330
Authors: Nuccia Morici; Lorenzo Moja; Valentina Rosato; Alice Sacco; Antonio Mafrici; Silvio Klugmann; Maurizio D'Urbano; Carlo La Vecchia; Stefano De Servi; Stefano Savonitto Journal: Intern Emerg Med Date: 2014-01-14 Impact factor: 3.397
Authors: R F Storey; K P Bliden; R Ecob; A Karunakaran; K Butler; C Wei; U Tantry; P A Gurbel Journal: J Thromb Haemost Date: 2011-09 Impact factor: 5.824
Authors: Duykhanh P Ceppa; Ian J Welsby; Tracy Y Wang; Mark W Onaitis; Betty C Tong; David H Harpole; Thomas A D'Amico; Mark F Berry Journal: Ann Thorac Surg Date: 2011-10-05 Impact factor: 4.330